ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-37C12056
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global 10 Valent Pneumococcal Polysaccharide Vaccine Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-37C12056
Report
June 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Sinovac
Kangtai Bio
CDIBP
Walvax

23-Valent Pneumococcal Polysaccharide Vaccine Market Size

In 2024, the global market size of 23-Valent Pneumococcal Polysaccharide Vaccine was estimated to be worth US$ 1211 million and is forecast to reach approximately US$ 2380 million by 2031 with a CAGR of 10.3% during the forecast period 2025-2031.

23-Valent Pneumococcal Polysaccharide Vaccine Market

23-Valent Pneumococcal Polysaccharide Vaccine Market

23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.
Market Drivers:
The 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) market is driven by the increasing prevalence of pneumococcal infections, particularly among high-risk populations such as the elderly, children, and immunocompromised individuals. Governments and health organizations worldwide are promoting vaccination programs to reduce the burden of pneumococcal diseases, which has significantly boosted market growth. Additionally, rising awareness about the importance of preventive healthcare and advancements in vaccine manufacturing technologies contribute to the increased adoption of PPSV23 vaccines.
Market Challenges:
However, the market faces challenges such as the high cost of vaccination, which limits accessibility in low- and middle-income countries. Moreover, the competition from newer pneumococcal conjugate vaccines (PCVs), which offer broader coverage and are preferred for pediatric use, poses a threat to PPSV23's market share. Another concern is vaccine hesitancy and misinformation, which can hinder immunization efforts and impact the overall market growth.
Merck is the largest manufacturers of 23-Valent pneumococcal polysaccharide vaccine in the world, has a share about 78%. Other players include Sinovac, Kangtai Bio, CDIBP, Walvax, etc. United States is dominating the global 23-Valent pneumococcal polysaccharide vaccine market, has a share nearly 78% in terms of production. The largest market is United States, holds a share about 48%, followed by China and Europe, with around 25% and 22% market share respectively.

Report Scope

This report aims to provide a comprehensive presentation of the global market for 23-Valent Pneumococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 23-Valent Pneumococcal Polysaccharide Vaccine.
The 23-Valent Pneumococcal Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 23-Valent Pneumococcal Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of 23-Valent Pneumococcal Polysaccharide Vaccine Market Report

Report Metric Details
Report Name 23-Valent Pneumococcal Polysaccharide Vaccine Market
Forecasted market size in 2031 approximately US$ 2380 million
CAGR 10.3%
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • For Children (Over 2 Years Old)
  • For Adult
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Sinovac, Kangtai Bio, CDIBP, Walvax
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of 23-Valent Pneumococcal Polysaccharide Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, 23-Valent Pneumococcal Polysaccharide Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the 23-Valent Pneumococcal Polysaccharide Vaccine Market size in 2031?

Ans: The 23-Valent Pneumococcal Polysaccharide Vaccine Market size in 2031 will be approximately US$ 2380 million.

What is the Merck share in 23-Valent Pneumococcal Polysaccharide Vaccine Market?

Ans: Merck is the largest manufacturers of 23-Valent pneumococcal polysaccharide vaccine in the world, has a share about 78%.

What is the 23-Valent Pneumococcal Polysaccharide Vaccine Market share by region?

Ans: The largest market is United States, holds a share about 48%, followed by China and Europe, with around 25% and 22% market share respectively.

Who are the main players in the 23-Valent Pneumococcal Polysaccharide Vaccine Market report?

Ans: The main players in the 23-Valent Pneumococcal Polysaccharide Vaccine Market are Merck, Sinovac, Kangtai Bio, CDIBP, Walvax

What are the Application segmentation covered in the 23-Valent Pneumococcal Polysaccharide Vaccine Market report?

Ans: The Applications covered in the 23-Valent Pneumococcal Polysaccharide Vaccine Market report are For Children (Over 2 Years Old), For Adult

What are the Type segmentation covered in the 23-Valent Pneumococcal Polysaccharide Vaccine Market report?

Ans: The Types covered in the 23-Valent Pneumococcal Polysaccharide Vaccine Market report are Single Dose Vial, Pre-filled Syringe

Recommended Reports

Pneumococcal Vaccines

Meningococcal Vaccines

Pediatric and RSV Vaccines

1 Study Coverage
1.1 23-Valent Pneumococcal Polysaccharide Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 Market by Application
1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 For Children (Over 2 Years Old)
1.3.3 For Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2020-2031
2.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2020-2031
2.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region: 2024 Versus 2031
2.3 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2020-2031)
2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2020-2025
2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2026-2031)
2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2031)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2020-2025
2.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2026-2031)
2.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2020-2031)
3.1.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Type (2020-2031)
3.1.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2031)
3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2020-2031)
3.1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2020-2031)
3.1.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2020-2031)
3.1.3 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2031)
3.2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Application (2020-2031)
3.2.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2031)
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2020-2031)
3.2.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2020-2031)
3.2.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2020-2031)
3.2.3 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Single Dose Vial of 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application
3.3.2 Pre-filled Syringe of 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application
4 Global 23-Valent Pneumococcal Polysaccharide Vaccine by Manufacturers
4.1 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers by Sales (2020-2025)
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturer (2020-2025)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers by Revenue (2020-2025)
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturer (2020-2025)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturer (2020-2025)
4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Covered: Ranking by Revenue
4.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Product Type
4.5.1 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into 23-Valent Pneumococcal Polysaccharide Vaccine Market
4.5.3 Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type and Application
4.5.4 Single Dose Vial Market Sales of 23-Valent Pneumococcal Polysaccharide Vaccine by Manufacturer
4.5.5 Pre-filled Syringe Market Sales of 23-Valent Pneumococcal Polysaccharide Vaccine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Merck
5.1.1 Merck Company Information
5.1.2 Merck Description, Business Overview
5.1.3 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
5.1.4 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Product in 2024
5.1.6 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application in 2024
5.1.7 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Area in 2024
5.1.8 Merck Recent Developments
5.2 Sinovac
5.2.1 Sinovac Company Information
5.2.2 Sinovac Description, Business Overview
5.2.3 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
5.2.4 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Product in 2024
5.2.6 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application in 2024
5.2.7 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Area in 2024
5.2.8 Sinovac Recent Developments
5.3 Kangtai Bio
5.3.1 Kangtai Bio Company Information
5.3.2 Kangtai Bio Description, Business Overview
5.3.3 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
5.3.4 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Product in 2024
5.3.6 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application in 2024
5.3.7 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Area in 2024
5.3.8 Kangtai Bio Recent Developments
5.4 CDIBP
5.4.1 CDIBP Company Information
5.4.2 CDIBP Description, Business Overview
5.4.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
5.4.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Product in 2024
5.4.6 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application in 2024
5.4.7 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Area in 2024
5.4.8 CDIBP Recent Developments
5.5 Walvax
5.5.1 Walvax Company Information
5.5.2 Walvax Description, Business Overview
5.5.3 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
5.5.4 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Product in 2024
5.5.6 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application in 2024
5.5.7 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Area in 2024
5.5.8 Walvax Recent Developments
6 North America
6.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2020-2031
6.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
6.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2031)
6.2.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2031)
6.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2020-2025)
6.4 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Region
7.2.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2020-2031)
7.2.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2020-2031)
7.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2020-2025)
7.4 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2025)
8 Europe
8.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2020-2031
8.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
8.2.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2031)
8.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2031)
8.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2020-2025)
8.4 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2020-2031
9.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
9.2.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2031)
9.2.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2031)
9.3 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2020-2025)
9.4 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
10.2.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2031)
10.2.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2031)
10.3 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2020-2025)
10.4 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 23-Valent Pneumococcal Polysaccharide Vaccine Supply Chain Analysis
11.2 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials and Upstream Suppliers
11.3 23-Valent Pneumococcal Polysaccharide Vaccine Clients Analysis
11.4 23-Valent Pneumococcal Polysaccharide Vaccine Sales Channel and Sales Model Analysis
11.4.1 23-Valent Pneumococcal Polysaccharide Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 23-Valent Pneumococcal Polysaccharide Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
12 23-Valent Pneumococcal Polysaccharide Vaccine Market Dynamics
12.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
12.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
12.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
12.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Merck
Sinovac
Kangtai Bio
CDIBP
Walvax
List of Tables
 Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K Units)
 Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturer (2020-2025)
 Table 18. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2024)
 Table 24. 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into 23-Valent Pneumococcal Polysaccharide Vaccine Market
 Table 26. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Merck Company Information
 Table 29. Merck Description and Business Overview
 Table 30. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product
 Table 31. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Merck Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Product in 2024
 Table 33. Merck Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2024
 Table 34. Merck Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Area in 2024
 Table 35. Merck Recent Developments
 Table 36. Sinovac Company Information
 Table 37. Sinovac Description and Business Overview
 Table 38. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product
 Table 39. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Sinovac Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Product in 2024
 Table 41. Sinovac Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2024
 Table 42. Sinovac Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Area in 2024
 Table 43. Sinovac Recent Developments
 Table 44. Kangtai Bio Company Information
 Table 45. Kangtai Bio Description and Business Overview
 Table 46. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product
 Table 47. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Kangtai Bio Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Product in 2024
 Table 49. Kangtai Bio Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2024
 Table 50. Kangtai Bio Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Area in 2024
 Table 51. Kangtai Bio Recent Developments
 Table 52. CDIBP Company Information
 Table 53. CDIBP Description and Business Overview
 Table 54. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product
 Table 55. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. CDIBP Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Product in 2024
 Table 57. CDIBP Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2024
 Table 58. CDIBP Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Area in 2024
 Table 59. CDIBP Recent Developments
 Table 60. Walvax Company Information
 Table 61. Walvax Description and Business Overview
 Table 62. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product
 Table 63. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Walvax Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Product in 2024
 Table 65. Walvax Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2024
 Table 66. Walvax Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Area in 2024
 Table 67. Walvax Recent Developments
 Table 68. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K Units)
 Table 69. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2026-2031) & (K Units)
 Table 70. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 71. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 72. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2020-2025) & (K Units)
 Table 73. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2025) & (K Units)
 Table 74. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K Units)
 Table 75. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2026-2031) & (K Units)
 Table 76. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 77. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 78. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2020-2025) & (K Units)
 Table 79. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2025) & (K Units)
 Table 80. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K Units)
 Table 81. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2026-2031) & (K Units)
 Table 82. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 83. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 84. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2020-2025) & (K Units)
 Table 85. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2025) & (K Units)
 Table 86. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K Units)
 Table 87. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2026-2031) & (K Units)
 Table 88. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 89. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 90. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2020-2025) & (K Units)
 Table 91. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2025) & (K Units)
 Table 92. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K Units)
 Table 93. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2026-2031) & (K Units)
 Table 94. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 95. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 96. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2020-2025) & (K Units)
 Table 97. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2025) & (K Units)
 Table 98. 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials, Industry Status and Trend
 Table 99. 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials and Upstream Suppliers
 Table 100. 23-Valent Pneumococcal Polysaccharide Vaccine Clients Status and Trend
 Table 101. 23-Valent Pneumococcal Polysaccharide Vaccine Typical Clients
 Table 102. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
 Table 103. 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends
 Table 104. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
 Table 105. 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
 Table 106. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
 Table 107. Research Programs/Design for This Report
 Table 108. Key Data Information from Secondary Sources
 Table 109. Key Data Information from Primary Sources
 Table 110. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Product Picture
 Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2024 & 2031
 Figure 4. Single Dose Vial Product Picture
 Figure 5. Pre-filled Syringe Product Picture
 Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2024 & 2031
 Figure 8. For Children (Over 2 Years Old)
 Figure 9. For Adult
 Figure 10. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
 Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size 2020-2031 (US$ Million)
 Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2020-2031 (K Units)
 Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Region (2020-2031)
 Figure 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2031)
 Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2020-2031)
 Figure 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2020-2031)
 Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2020-2031)
 Figure 21. 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 22. Single Dose Vial of 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Pre-filled Syringe of 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturer in 2024
 Figure 25. 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Single Dose Vial Market Sales Proportion by Manufacturer in 2024
 Figure 27. Pre-filled Syringe Market Sales Proportion by Manufacturer in 2024
 Figure 28. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2020-2031 (US$ Million)
 Figure 29. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
 Figure 30. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
 Figure 31. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2020-2031 (US$ Million)
 Figure 32. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
 Figure 35. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
 Figure 36. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 37. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2020-2031)
 Figure 38. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2020-2031)
 Figure 39. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
 Figure 40. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
 Figure 41. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2020-2025)
 Figure 44. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
 Figure 45. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
 Figure 46. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
 Figure 50. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
 Figure 51. 23-Valent Pneumococcal Polysaccharide Vaccine Supply Chain (Upstream and Downstream Market)
 Figure 52. Global Production Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine Raw Materials by Region in 2024
 Figure 53. 23-Valent Pneumococcal Polysaccharide Vaccine Distribution Channels
 Figure 54. Global 23-Valent Pneumococcal Polysaccharide Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 55. Global 23-Valent Pneumococcal Polysaccharide Vaccine Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Pneumococcal 13 valent Conjugate Vaccine Market Research Report 2024
Global 13 Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Research Report 2024
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Research Report 2025
Global Pneumococcal Vaccination Market Research Report 2025
Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Pneumococcal Polysaccharide Vaccine Market Research Report 2024
Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
13 Valent Pneumococcal Polysaccharide Conjugate Vaccine PCV13 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pneumococcal Vaccine Polyvalent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Research Report 2024
Global 13 Valent Pneumococcal Conjugate Vaccine Market Research Report 2024
Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Research Report 2025
23 valent Pneumococcal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Papillomavirus 9 Valent Vaccine Market Research Report 2024
Global Meningococcal Polysaccharide Vaccine Market Research Report 2025
Global Pneumonia Vaccine Market Insights Forecast to 2030
Cervical Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pneumococcal Conjugate Vaccine PCV Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
4 valent HPV Vaccine 4vHPV Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Streptococcus Pneumoniae Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions